Selikoff IJ: The occurrence of pleural calcification among asbestos insulation workers . Ann NY Acad Sci1965;132:351-367.
2.
Jacob G., Bohlig H.: Roentgenological complications in pulmonary asbestosis. RöFo1955;83: 515-525.
3.
Hillerdal G. : The pathogenesis of pleural plaques and pulmonary asbestosis: Possibilities and impossibilities. Eur J Respir Dis1980 ; 61:129-138.
4.
Davis J.: Mineral fibre carcinogenesis: Experimental data relating to the importance of fibre type, size, deposition, dissolution and migration; in Bignon J, Peto J, Saracci R (eds): Non-Occupational Exposure to Mineral Fibres. Lyon, IARC Scientific Publications, 1989, pp 33-45.
5.
Rous V., Studeny J.: Aetiology of pleural plaques. Thorax1970;25:270-284.
6.
Bégin R., Rola-Pleszczynski M., Masse S.: Assessment of asbestosis in the sheep model by bronchoalveolar lavage . Thorax1983 ;38:449-457.
7.
Boutin C., Viallat Jr, Steinbauer J, Gaudichet A, Dufour G: Pleural plaques and environmental asbestosis in North Corsica; in Bignon J, Peto J, Saracci R (eds): Non-Occupational Exposure to Mineral Fibres. Lyon, IARC Scientific Publications, 1989.
8.
Taskinen E., Ahlman K., Wiikeri M.: A current hypothesis of the lymphatic transport of inspired dust to the parietal pleura. Chest1973; 64:193-196.
9.
Boutin C., Dumortier P., Rey F., Viallat J., De-Vuyst P.: Black spots concentrate oncogenic asbestos fibres in the parietal pleura. Am J Respir Crit Care Med1996;153:444-449.
10.
Holt PF: Translocation of inhaled dust to the pleura. Environ Res1983;31:212-220.
11.
Oberdörster G., Morrow PE, Spurny K.: Size dependent lymphatic short term clearance of amosite fibres in the lung ; in Dodgson (ed): Inhaled Particles IV. Oxford, Pergamon , 1988.
12.
Wang N-S.: The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. Am Rev Respir Dis1975 ;3:12-19.
13.
Mollo F., Bellis D., Magnani C., Delsedime L., Andrion A.: Hyaline splenic and hepatic plaques: Correlation with cirrhosis, pulmonary tuberculosis, and asbestos exposure. Arch Pathol Lab Med1993;117:1017-1021.
14.
Addison J., Browne K., Davis Jmg, Gruber UF: Asbestos fibres in parenteral medication. Regul ToxicolPharmacol1993;18:371-80.
15.
Lockey J., Lemasters G., Rice C., Hansen K., Levin L., Shipley R., Spitz H., Wiot J.: Refractory ceramic fibre exposure and pleural plaques. Am J Respir Crit Care Med1996;154:1405-1410.
16.
Garabrant DH , Fine LJ, Oliver C., Bernstein L., Peters J.: Abnormalities of pulmonary function and pleural disease among titanium metal production workers. Scand J Work Environ Health1987;13:47-51.
17.
Jones RN, Diem JE, Glindemeyer H., Weill H., Gilson JC: Progression of asbestos radiographic abnormalities: Relationships to estimates of dust exposure and annual decline in lung function; in Wagner JC (ed): Biological Effects of Mineral Fibres. Lyon, IARC Scientific Publications , 1979/1980.
18.
Andrion A., Pira E., Mollo F.: Pleural plaques at autopsy, smoking habits, and asbestos exposure . Eur J Respir Dis1984;65:125-130.
19.
Churg A.: 1. Non-neoplastic diseases caused by asbestos; 2. Neoplastic asbestos-induced diseases ; in Churg A, Green FHY (eds): Pathology of Occupational Lung Disease. New York, Igaku-Shoin , 1988.
20.
Hillerdal G. , Bariş Y.: Radiological study of pleural changes in relation to mesothelioma in Turkey. Thorax1983;38:443-448.
21.
Staples C.: Computed tomography in the evaluation of benign asbestos-related disorders . Radiol Clin North Am1992;30:1191-1207.
22.
Yates DH, Browne K., Stidolph PN, Neville E.: Asbestos-related bilateral diffuse pleural thickening: Natural history of radiographic and lung function abnormalities. Am J Respir Crit Care Med1996;153:301-306.
